Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eiger Biopharma (EIGR)

Eiger Biopharma (EIGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eiger Biopharma 2155 PARK BOULEVARD PALO ALTO CA 94306 USA

www.eigerbio.com P: 650-272-6138

Description:

Eiger BioPharmaceuticals, Inc. is a biopharmaceutical company which develops and manufactures drugs and therapies for the treatment of orphan diseases. Eiger BioPharmaceuticals, Inc., formerly known as Celladon Corporation, is based in Palo Alto, California.

Key Statistics

Overview:

Market Capitalization, $K 2,554
Enterprise Value, $K 16,384
Shares Outstanding, K 1,481
Annual Sales, $ 13,480 K
Annual Net Income, $ -96,780 K
Last Quarter Sales, $ 3,210 K
Last Quarter Net Income, $ -18,030 K
EBIT, $ -83,640 K
EBITDA, $ -82,120 K
60-Month Beta 1.83
% of Insider Shareholders 4.22%
% of Institutional Shareholders 62.46%
Float, K 1,418
% Float 95.78%
Short Volume Ratio 0.69

Growth:

1-Year Return -92.83%
3-Year Return -99.31%
5-Year Return -99.48%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 52.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -12.31 on 11/09/23
Next Earnings Date 05/09/24
Earnings Per Share ttm -59.16
EPS Growth vs. Prev Qtr 12.77%
EPS Growth vs. Prev Year 33.87%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 01/08/24

EIGR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -869.84%
Return-on-Assets % -112.70%
Profit Margin % -717.95%
Debt/Equity -25.46
Price/Sales 0.18
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.08
Interest Coverage -22.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar